Tetanus: Still a Threat: Clinical Case Report

Authors

DOI:

https://doi.org/10.24950/CC/86/19/1/2020

Keywords:

Clostridium tetani, Tetanus/complications, Tetanus/drug therapy, Spasm, Trismus

Abstract

Tetanus is a potentially fatal disease, preventable through vaccination, caused by neurotoxins produced by Clostridium tetani, which cease inhibitory neurotransmission. It presents a symptomatic triad: stiffness, muscular spasms and autonomic dysfunction. The therapeutic approach is essentially symptomatic, including wound cleaning, benzodiazepines, neuromuscular blockade, ventilatory support and antibiotic therapy. We present the clinical case of a 79-year-old female patient, with outdated tetanus vaccine, admitted in the context of an injury to the left wrist, without prophylaxis with tetanus immunoglobulin. Reassessed in the emergency 5 days after the event with trismus, opisthotonos, respiratory failure and dysautonomia. We proceeded to wound cleaning, immunoglobulin and antibiotic therapy administration, sedation, ventilatory support and we transferred the patient to an intensive care unit. It was a case without prophylaxis, showing that tetanus is still a threat that should alert us all to the immunological situation and compli- ance with the national vaccination plan.

Downloads

Download data is not yet available.

References

Moynan D, O’Riordan R, O’Connor R, Merry C. Tetanus – a rare but real threat. IDCases. 2018;12:16-17. doi: 10.1016/j.idcr.2018.02.004.

Chalya PL, Mabula JB, Dass RM, Mbelenge N, Mshana SE, Gilyoma JM. Ten-year experiences with tetanus at a Tertiary hospital in Northwestern Tanzania: A retrospective review of 102 cases. World J Emerg Surg. 2011;6:20. doi: 10.1186/1749 7922-6-20.

Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001; 87:477-87.

Thwaites CL. Tetanus. Pract Neurol.2002; 3:130–7.

Bjørnar H. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins. 2013;5:73-83. doi: 10.3390/toxins5010073.

Farrar JJ, Yen LM, Cook T, Fairweather N, Binh J, Parru CM. Tetanus. J Neurol Neurosurg Psychiatry. 2000;69:292–301.

Ogunrin OA. Tetanus – a review of current concepts in management. Benin J Postgrad Med. 2009; 46-61. doi:11: 10.4314/bjpm.v11i1.48828

Ablett JJL. Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit. In: Ellis M, editor. Symposium on tetanus in Great Britain. Boston: Leeds General Infirmary; 1967. p.1–10.

Okoromah CN, Lesi FE. Diazepam for treating tetanus. Cochrane Database Syst Rev. 2004;1:CD003954.

Chaturaka R, Deepika F, Senaka R. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014;18:217. doi: 10.1186/cc13797.

American Academy of Pediatrics. Summaries of Infection Diseases. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village:AAP; 2015. p.773-8.

Published

2021-12-08

How to Cite

1.
Carvalho C, Albuquerque A, Campante F. Tetanus: Still a Threat: Clinical Case Report. RPMI [Internet]. 2021 Dec. 8 [cited 2024 Dec. 18];27(1):33-6. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/184

Issue

Section

Case Reports

Most read articles by the same author(s)